NEW YORK, April 17, 2017 /PRNewswire/ --
According to a report published by Grand View Research, the global medical cannabis market size was valued at $11.4 billion in 2015, and is expected to reach $55.8 billion by 2025, or with a compound annual growth rate of 17.1 percent during the forecast period. The accelerating pace of cannabis legalization is considered as one of the major factors that drive the growth of the legal cannabis market. Last year, states such as Arkansas, Florida, North Dakota, Ohio, and Pennsylvania have legalized cannabis for medical use, or now bringing the total number of states where medical cannabis is legal to 28. ChineseInvestors.com, Inc. (OTC: CIIX), Canopy Growth Corporation (OTC: TWMJF), Mentor Capital, Inc. (OTC: MNTR), Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP), Kush Bottles, Inc. (OTC: KSHB)
Cannabidial (CBD) is one of the most prevalent compounds in the cannabis plant and it is considered to have significant medical benefits. CBD does have psychoactive effects and can be derived from hemp plants or marijuana plants. Matt Karnes of Greenwave Advisors is optimistic about the growth of the CBD market saying, "In terms of the CBD market size, I estimate an almost $3 billion market by 2021. Right now there are 15 states that allow CBD only - this is in addition to the 28 states plus DC that have legalized medical marijuana."
ChineseInvestors.com, Inc. (OTCQB: CIIX) on March 30th, announced that its investment in Breakwater MB, LLC, a cannabis-focused investment and consulting company. Building on the success that CIIX enjoyed through its investment in early-stage firm Medicine Man Technologies, the Company is pleased to announce another strategic investment in the cannabis industry.
Breakwater MB was formed by CIIX board member and former CFO, Paul Dickman as a means to invest capital in and provide consulting services to private, cannabis-focused companies as they transition into the public market. The invested capital will primarily be used to cover the costs of becoming a publicly traded company, a strategy CIIX expects will provide significant investment appreciation and opportunity for liquidity. All opportunities will be evaluated by the investment committee comprised of CIIX CEO, Warren Wang, Medicine Man Technologies (OTCQB: MDCL) CEO, Andy Williams, and Paul Dickman, the CFO of Medicine Man and managing member of Breakwater MB.
"By focusing on these transitional phase investments, it's our expectation that investors in Breakwater MB will enjoy significant capital appreciation in its investment due to the arbitrage in value between private and public companies, the growth through access to the capital markets, the firm's expertise and established network, as well as short-term liquidity due to investing in newly formed publicly traded companies," states Dickman.
Canopy Growth Corporation (OTC: TWMJF) on April 3rd announced that the Company has entered into an agreement to acquire rTrees Producers Limited ("rTrees") ("the Agreement"). rTrees is a late-stage ACMPR applicant based in Yorkton, Saskatchewan. Leveraging the award-winning emerging global brand, Tweed, and paying tribute to the vast prairie grasslands, rTrees will operate as Tweed Grasslands, producing high-quality Western-grown products to support the Tweed brand and the new flagship Tweed Main Street online store.
Mentor Capital, Inc. (OTCQB: MNTR) revealed on April 13th that it has initiated funding for its GlauCanna venture for the use of medical marijuana in the treatment of glaucoma patients. Mentor will provide funding and business management for any commercial development and holds an 80% interest. Mentor CEO, Chet Billingsley explains, "All current medicines in the $2.4 billion glaucoma market act on the same receptor family to reduce the intra-ocular pressure. Once that receptor is saturated, no further progress is made and pressure often increases again, destroying vision. Surgically installing valves in the eye or drilling out drainage pathways with a laser also often have time limited effectiveness. By leveraging the alternative receptor pathway of certain cannabis components Dr. Mandelkorn has observed a 40% reduction in intra-ocular pressure, back into the normal range, amongst patients that had otherwise saturated their existing eye medicine effectiveness. In an illustrative layman's example, a patient at the limit of other medication effectiveness had vision with corrected glasses reduced to 20/200 because of glaucoma damage. After a particular two week medical marijuana regime, the vision improved to 20/50 with observed tissue healing."
Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP) is a clinical stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. Our lead product candidate, anabasum, is a novel synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation, and fibrotic processes. On April 5th, the company explained that the Company will be proceeding with a single Phase 3 study to support a New Drug Application ("NDA") for anabasum for the treatment of diffuse cutaneous systemic sclerosis.
Kush Bottles, Inc. (OTCQB: KSHB) is a provider of packaging, supplies, accessories and branding solutions for the regulated cannabis industry. On March 1st, the company announced that it has added two new distribution partners in Hawaii and Puerto Rico, two key medical cannabis markets. The move will significantly enhance the company's ability to attract and service new customers in these emerging markets. The company's Hawaii distribution partner will service the island's dispensaries that provide products to registered patients. Hawaii's reciprocity program will also allow sales to patients with valid medical marijuana cards who are visiting from other states. According to the Hawaii Department of Business, Economic Development and Tourism, Hawaii had approximately 9 million tourists visit in 2016.
Please SIGN UP NOW at http://www.FinancialBuzz.com To Receive Alerts on Trending Financial News from all these companies. "The Latest Buzz in Financial News"
Subscribe Now! Watch us report from NYSE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.
For further information:
Media Contact e-mail: firstname.lastname@example.org